Psilera’s Award-Winning Co-Founders To Be Featured Speakers at Upcoming Industry Conferences Across the Country. Post published:October 20, 2022 Post category:Press Release
Psilera Receives First Patent Allowance for Transdermal Patch Formulations Post published:September 14, 2022 Post category:Press Release
Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders Post published:August 10, 2022 Post category:Press Release
Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago Post published:March 24, 2022 Post category:Press Release